Effects of once-weekly semaglutide on major adverse cardiovascular events in patients with type 2 diabetes and polyvascular disease: a post hoc analysis of the SUSTAIN 6 trial
25 August 2023 (07:30 - 18:30)
Organised by: 
About the speaker
Hillel Yaffe Medical Center, Hadera (Israel)
5 More presentations in this session
Doctor D. Sa (Funchal, PT)
Doctor F. Kin (Hamamatsu, JP)
Access the full session
The Event
ESC Congress 2023
25 August - 28 August 2023
You may be interested in
Congress Presentation
Congress Presentation
